MTOR and diabetes mellitus: This implies that, in diabetes setting, impaired mTOR pathway and weakened productions of IL-15 and IGF-1, exhibit mutual effects and may reach a low-level equilibrium state, an important mechanism that causes dysfunction of DETC and defective wound repair.